Incidence of herpes zoster and its complications in Germany, 2005-2009

Journal of Infection

Volumn 70, Issue 2, 2015, Pages 178-186

  Hillebrand, Kathrin ^a   Bricout, Hélène ^b   Schulze Rath, Renate ^c   Schink, Tania ^a   Garbe, Edeltraut ^a,d  

^a LEIBNIZ INSTITUTE FOR PREVENTION RESEARCH AND EPIDEMIOLOGY BIPS   (Germany)

^b SANOFI PASTEUR   (France)

^c Sanofi Pasteur MSD GmbH   (Germany)

^d UNIVERSITY OF BREMEN   (Germany)

Author keywords

Epidemiology; Herpes zoster; Incidence rate; Varicella zoster virus; Zoster complications

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; FAMCICLOVIR; VALACICLOVIR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIVIRAL THERAPY; ARTICLE; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; DISEASE SURVEILLANCE; DRUG EFFECT; FEMALE; GERMANY; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HOSPITALIZATION; HUMAN; IMMUNE STATUS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED PATIENT; INFANT; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEWBORN; POSTHERPETIC NEURALGIA; PRESCHOOL CHILD; PRESCRIPTION; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; SYSTEMIC THERAPY; TREND STUDY; VERY ELDERLY; VIRUS MENINGITIS; YOUNG ADULT; COMPLICATION; INCIDENCE; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; GERMANY; HERPES ZOSTER; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84921026843     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.08.018     Document Type: Article

References (41)

1. Gross G., Schofer H., Wassilew S., Friese K., Timm A., Guthoff R., et al. Herpes zoster guideline of the German Dermatology Society (DDG). J Clin Virol 2003, 26(3):277-289. [Ref Type: Generic].
2. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 1965 Jan, 58:9-20.
3. Wittek M., Doerr H.W., Allwinn R. Varicella and herpes zoster. Part 1: virology, epidemiology, clinical picture, laboratory diagnostics. Med Klin (Munich) 2010 May, 105(5):334-338.
4. Pinchinat S., Cebrian-Cuenca A.M., Bricout H., Johnson R.W. Similar herpes zoster incidence across Europe: results from a systematic literature review. BMC Infect Dis 2013, 13:170.
5. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 2001 Oct, 127(2):305-314.
6. Miller E., Marshall R., Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 1993, 4(4):222-230. [Ref Type: Generic].
7. Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001 May 15, 32(10):1481-1486.
8. Dworkin R.H., Portenoy R.K. Pain and its persistence in herpes zoster. Pain 1996 Oct, 67(2-3):241-251.
9. Opstelten W., Mauritz J.W., de Wit N.J., van Wijck A.J., Stalman W.A., van Essen G.A. Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 2002 Oct, 19(5):471-475.
10. Gnann J.W. Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 2002 Oct 15, 186(Suppl. 1):S91-S98.
11. Gonzalez C.S., Sarazin M., Turbelin C., Lasserre A., Pelat C., Bonmarin I., et al. Herpes zoster: burden of disease in France. Vaccine 2010 Nov 23, 28(50):7933-7938.
12. Meister W., Neiss A., Gross G., Doerr H., Hobel W., Malin J., et al. Demography, symptomatology, and course of disease in ambulatory zoster patients. A physician-based survey in Germany. Intervirology 1998, 41(6):272-277.
13. Paul E., Thiel T. Zur Epidemiologie der Varizella-Zoster-Infektion. Ergebnisse einer prospektiven Erhebung im Landkreis Ansbach. Hautarzt 1996, 47:604-609. [Ref Type: Generic].
14. Insinga R.P., Itzler R.F., Pellissier J.M., Saddier P., Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 2005 Aug, 20(8):748-753.
15. Leung J., Harpaz R., Molinari N.A., Jumaan A., Zhou F. Herpes zoster incidence among insured persons in the United States, 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011 Feb 1, 52(3):332-340.
16. Gialloreti L.E., Merito M., Pezzotti P., Naldi L., Gatti A., Beillat M., et al. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010, 10:230.
17. Schiffner-Rohe J., Jow S., Lilie H.M., Koster I., Schubert I. Herpes zoster in Germany. A retrospective analyse of SHL data. MMW Fortschr Med 2010 Jan 14, 151(Suppl. 4):193-197.
18. Weitzman D., Shavit O., Stein M., Cohen R., Chodick G., Shalev V. A population based study of the epidemiology of herpes zoster and its complications. J Infect 2013 Nov, 67(5):463-469.
19. Ultsch B., Koester I., Reinhold T., Siedler A., Krause G., Icks A., et al. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany. Eur J Health Econ 2013 Dec, 14(6):1015-1026.
20. Yawn B.P., Saddier P., Wollan P.C., St Sauver J.L., Kurland M.J., Sy L.S. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 2007 Nov, 82(11):1341-1349.
21. Garbe E., Suling M., Kloss S., Lindemann C., Schmid U. Linkage of mother-baby pairs in the German Pharmacoepidemiological Research Database. Pharmacoepidemiol Drug Saf 2011, 20(3):258-264.
22. Pigeot I., Ahrens W. Establishment of a pharmacoepidemiological database in Germany: methodological potential, scientific value and practical limitations. Pharmacoepidemiol Drug Saf 2008 Mar, 17(3):215-223.
23. Daly L.E. Confidence limits made easy: interval estimation using a substitution method. Am J Epidemiol 1998 Apr 15, 147(8):783-790.
24. Gesundheitsberichterstattung des Bundes 2013, Available at:, [accessed 08.10.13]. http://www.gbe-bund.de/oowa921-install/servlet/oowa/aw92/dboowasys921.xwdevkit/xwd_init?gbe.isgbetol/xs_start_neu/%26p_aid=3%26p_aid=21378921%26nummer=1000%26p_sprache=D%26p_indsp=-%26p_aid=67904213.
25. Newcombe R., Altman D. Proportions and their differences. Statistics with confidence 2000, 45-56. British Medical Journal Books, Bristol. D. Altman, D. Machin, T. Bryant, M. Gardner (Eds.).
26. Gauthier A., Breuer J., Carrington D., Martin M., Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect 2009 Jan, 137(1):38-47.
27. Stein J.M., Warfield C.A. Herpes zoster and postherpetic neuralgia. Hosp Pract (Off Ed) 1982 Sep, 17(9). 96A-O.
28. Ultsch B., Siedler A., Rieck T., Reinhold T., Krause G., Wichmann O. Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis 2011, 11:173.
29. Cebrian-Cuenca A.M., Diez-Domingo J., San-Martin-Rodriguez M., Puig-Barbera J., Navarro-Perez J. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain. BMC Infect Dis 2011, 11:302.
30. Chidiac C., Bruxelle J., Daures J.P., Hoang-Xuan T., Morel P., Leplege A., et al. Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 2001 Jul 1, 33(1):62-69.
31. Opstelten W., van Essen G.A., Schellevis F., Verheij T.J., Moons K.G. Gender as an independent risk factor for herpes zoster: a population-based prospective study. Ann Epidemiol 2006 Sep, 16(9):692-695.
32. Mullooly J.P., Riedlinger K., Chun C., Weinmann S., Houston H. Incidence of herpes zoster, 1997-2002. Epidemiol Infect 2005 Apr, 133(2):245-253.
33. Pierik J.G., Gumbs P.D., Fortanier S.A., Van Steenwijk P.C., Postma M.J. Epidemiological characteristics and societal burden of varicella zoster virus in the Netherlands. BMC Infect Dis 2012, 12:110.
34. Wittek M., Doerr H.W., Allwinn R. Varicella and herpes zoster. Part 2: therapy and prevention. Med Klin (Munich) 2010 Jun, 105(6):399-403.
35. Cebrian-Cuenca A.M., Diez-Domingo J., Rodriguez M.S., Puig-Barbera J., Navarro-Perez J. Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain). BMC Fam Pract 2010, 11:33.
36. de M.H., Berbers G., Hahne S., Rumke H., van den Hof S., de W.A., et al. The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 2006 May 1, 24(18):3946-3952.
37. Studahl M., Petzold M., Cassel T. Disease burden of herpes zoster in Sweden - predominance in the elderly and in women - a register based study. BMC Infect Dis 2013, 13:586.
38. Bouhassira D., Chassany O., Gaillat J., Hanslik T., Launay O., Mann C., et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain 2012 Feb, 153(2):342-349.
39. Giersiepen K., Pohlabeln H., Egidi G., Pigeot I. Quality of diagnostic ICD coding for outpatients in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007 Aug, 50(8):1028-1038.
40. Langan S.M., Smeeth L., Margolis D.J., Thomas S.L. Herpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort study. PLoS Med 2013, 10(4):e1001420.
41. European Centre for Disease Prevention and Control (ECDC). Available at: [accessed 11.08.14]. Ref Type: Online Source. http://vaccine-schedule.ecdc.europa.eu/Pages/Scheduler.aspx.